Natalia Losada-Trujillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Natalia Losada-Trujillo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Andrés Felipe Morcillo Muñoz
Clinical epileptology, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez” (INNNMVS), Ciudad de México, México
1 shared publication - Brahiam Alejandro Ramírez-Vargas
Affiliations Faculty of Medicine, Universidad Nacional de Colombia, Bogotá D.C, Colombia, Hospital Universitario Nacional de Colombia, Bogotá D.C, Colombia, Health Technologies and Policies Assessment Group (GETS), Bogotá D.C, Colombia
1 shared publication - David Ríos Patiño
Department of Neurology, Fundación Instituto Neurológico de Colombia, Medellín, Colombia
1 shared publication - Diana Margarita Pinto-Masis
Independent Researcher
1 shared publication Diego Alberto Cuellar-Ortiz
Minist Hlth & Social Protect Colombia, Bogota, Colombia
1 shared publication- Diego Cerecero-García
Public Health Policy Evaluation Unit, Faculty of Medicine, School of Public Health, Imperial College London
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0345959
Safety and effectiveness of hormonal vs non-hormonal or no contraception in women with hypertension and future fertility desire: A broad-scope systematic review
Objective: To evaluate the safety and effectiveness of hormonal contraceptives compared to non-hormonal methods or no contraception in hypertensive women seeking future fertility. Data sources: Searches were conducted in Medline, Embase, CENTRAL, and LILACS (September –October, 2022), with updates on September, 2023, and August, 2024. Clinical trial records, regulatory agencies, and gray literature were also consulted (June, 2022; August, 2023; September, 2024). Methods: Eligible studies that assessed safety (major adverse cardiovascular events, pelvic inflammatory disease, vaginal infections, loss of fertility, discontinuation, worsening hypertension, peripheral arterial disease, venous thromboembolism, weight gain, liver or kidney function changes) or effectiveness (pregnancies/Pearl index) of hormonal contraceptives in hypertensive women. Eligible designs included clinical trials, cohort and case control studies, case series, case reports, and adverse event data. Two reviewers independently screened titles/abstracts, reviewed full texts, selected studies, extracted data, and assessed bias (ROBINS-I: cohorts), methodological quality (Newcastle Ottawa: case-control), and critical appraisal (Joanna Briggs Institute: case series). Certainty of evidence was evaluated using GRADE. Evidence was synthesized quantitatively and qualitatively by contraceptive and outcome. Results: Of 32,225 records screened, 17 studies were included. Combined oral contraceptives may increase hemorrhagic cerebrovascular disease (OR: 1.64 (95% CI 1.08–2.50, certainty: low). Evidence is very uncertain about their effects on preventing pregnancies, and safety related to ischemic cerebrovascular disease, myocardial infarction, venous thromboembolism, weight gain, hypertension, kidney function, and lipid profile. Similarly, the effects of progestin-only pills, injectables, and vaginal rings on cardiovascular and metabolic outcomes remain highly uncertain. Certainty is also very low for combined oral contraceptives or progestogen-only pills regarding cerebrovascular disease, myocardial infarction (OR: 1.15, 95% CI 0.60–2.19), and peripheral arterial disease. Conclusions: Low-certainty evidence suggests that combined oral contraceptives may increase hemorrhagic cerebrovascular disease in hypertensive women, whereas evidence for the other assessed safety and effectiveness outcomes is very low.
- 31 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0345959
Open AccessSafety and effectiveness of hormonal vs non-hormonal or no contraception in women with hypertension and future fertility desire: A broad-scope systematic review
Objective: To evaluate the safety and effectiveness of hormonal contraceptives compared to non-hormonal methods or no contraception in hypertensive women seeking future fertility. Data sources: Searches were conducted in Medline, Embase, CENTRAL, and LILACS (September –October, 2022), with updates on September, 2023, and August, 2024. Clinical trial records, regulatory agencies, and gray literature were also consulted (June, 2022; August, 2023; September, 2024). Methods: Eligible studies that assessed safety (major adverse cardiovascular events, pelvic inflammatory disease, vaginal infections, loss of fertility, discontinuation, worsening hypertension, peripheral arterial disease, venous thromboembolism, weight gain, liver or kidney function changes) or effectiveness (pregnancies/Pearl index) of hormonal contraceptives in hypertensive women. Eligible designs included clinical trials, cohort and case control studies, case series, case reports, and adverse event data. Two reviewers independently screened titles/abstracts, reviewed full texts, selected studies, extracted data, and assessed bias (ROBINS-I: cohorts), methodological quality (Newcastle Ottawa: case-control), and critical appraisal (Joanna Briggs Institute: case series). Certainty of evidence was evaluated using GRADE. Evidence was synthesized quantitatively and qualitatively by contraceptive and outcome. Results: Of 32,225 records screened, 17 studies were included. Combined oral contraceptives may increase hemorrhagic cerebrovascular disease (OR: 1.64 (95% CI 1.08–2.50, certainty: low). Evidence is very uncertain about their effects on preventing pregnancies, and safety related to ischemic cerebrovascular disease, myocardial infarction, venous thromboembolism, weight gain, hypertension, kidney function, and lipid profile. Similarly, the effects of progestin-only pills, injectables, and vaginal rings on cardiovascular and metabolic outcomes remain highly uncertain. Certainty is also very low for combined oral contraceptives or progestogen-only pills regarding cerebrovascular disease, myocardial infarction (OR: 1.15, 95% CI 0.60–2.19), and peripheral arterial disease. Conclusions: Low-certainty evidence suggests that combined oral contraceptives may increase hemorrhagic cerebrovascular disease in hypertensive women, whereas evidence for the other assessed safety and effectiveness outcomes is very low.
- Open Access
- 18 December 2024
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 10 (3) , 2461096
Strengthening the Resilience of Objective-Oriented Health System Reforms. Analysis of the Left-Turn in the Health Reform Proposals in Mexico (2019) and Colombia (2023)
This article explores the political and institutional factors that led two leftist governments to propose sweeping, rather than incremental, changes to earlier objective-oriented health systems reforms. One is the government of Mexico led by President Andrés Manuel López Obrador, who in 2019 proposed to replace reforms approved in 2003. His proposal was passed by Congress and implemented. The other is the government of President Gustavo Petro in Colombia, who in 2023 recommended the replacement of the health reform implemented in Colombia since 1993. His proposal was rejected by Congress. Drawing on historical institutionalism, we analyzed the interactions among actors and institutions that shaped their reform proposals, focusing on policy feedback effects and veto points. We examined news articles, government and policy documents, electoral results, presidential approval ratings, and legislative voting records. We also conducted in-depth interviews with key actors about the factors behind the need for reform, the policy proposals, and the public and legislative debates. In both countries, we found that a combination of policy feedback effects (political ideology beliefs, and policy legacies that shape public perceptions and expectations) and veto points (the perceived strength of the president vis-à-vis reform opponents) help explain the decisions to propose such significant changes to the health care systems. Based on these findings, we offer initial recommendations for safeguarding objective-oriented health system reforms in lower-middle and upper-middle-income countries facing stark political change, especially in polarized contexts. Objective-oriented health system reforms should be evidence-based and supported by long-term financing, delivery, management, and evaluation plans. For long-term resilience, they also need multiple networks to secure them, including citizens well informed about their benefits, health workers with a sense of ownership, and legal protections.
- 18 December 2024
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 10 (3) , 2461096
Open AccessStrengthening the Resilience of Objective-Oriented Health System Reforms. Analysis of the Left-Turn in the Health Reform Proposals in Mexico (2019) and Colombia (2023)
This article explores the political and institutional factors that led two leftist governments to propose sweeping, rather than incremental, changes to earlier objective-oriented health systems reforms. One is the government of Mexico led by President Andrés Manuel López Obrador, who in 2019 proposed to replace reforms approved in 2003. His proposal was passed by Congress and implemented. The other is the government of President Gustavo Petro in Colombia, who in 2023 recommended the replacement of the health reform implemented in Colombia since 1993. His proposal was rejected by Congress. Drawing on historical institutionalism, we analyzed the interactions among actors and institutions that shaped their reform proposals, focusing on policy feedback effects and veto points. We examined news articles, government and policy documents, electoral results, presidential approval ratings, and legislative voting records. We also conducted in-depth interviews with key actors about the factors behind the need for reform, the policy proposals, and the public and legislative debates. In both countries, we found that a combination of policy feedback effects (political ideology beliefs, and policy legacies that shape public perceptions and expectations) and veto points (the perceived strength of the president vis-à-vis reform opponents) help explain the decisions to propose such significant changes to the health care systems. Based on these findings, we offer initial recommendations for safeguarding objective-oriented health system reforms in lower-middle and upper-middle-income countries facing stark political change, especially in polarized contexts. Objective-oriented health system reforms should be evidence-based and supported by long-term financing, delivery, management, and evaluation plans. For long-term resilience, they also need multiple networks to secure them, including citizens well informed about their benefits, health workers with a sense of ownership, and legal protections.
- Open Access
- 15 June 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (4) , 1437-1444
Epilepsy in inmate patients seen in a high complexity reference hospital in Colombia: A cross‐sectional study
Objective: To describe the sociodemographic and clinical characteristics of imprisoned patients with epilepsy seen at Samaritana University Hospital (HUS) in Bogotá D.C., between January 2017 and November 2020.Methods: Cross‐sectional cohort study of inmate patients over 18 years of age seen at HUS between January 2017 and November 2020, with a discharge diagnosis of epilepsy. A descriptive univariate analysis of patient sociodemographic and clinical characteristics was carried out.Results: Overall, 92 patients were included, 95.7% were males with a median age of 32 years (IQR: 26–44); 65% were assessed in the outpatient clinic; median hospital length of stay was 2 days (IQR: 0) and 7.6% required admission to the intensive care unit; 75% had focal onset epilepsy, 63.04% with undetermined etiology 31.52% with structural causes. Polytherapy was found in 53.3%, valproic acid being the most frequently used antiseizure medication in 59.78%; lack of adherence was reported in 15.22% and inadequate seizure control in 81.52%; status epilepticus occurred in 5.34%. A total of 31 EEG recordings and 53 brain images were performed, of which, 29% and 39.62%, respectively, were abnormal. Non‐epileptic paroxysmal events were diagnosed in 5.34%, while organic or psychiatric comorbidities were found in 25%, and the use of psychoactive substances was documented in 17.39%. Upon discharge, 93.47% had no disability, and only 45.65% returned for outpatient follow‐up.Significance: The clinical profile was of men in the fourth decade of life with focal onset epilepsy characterized by high seizure frequency, most of whom were receiving antiseizure medication, with a high proportion of polytherapy. The results are a point of departure for prospective studies designed to identify points to intervene and improve healthcare for inmates with epilepsy.Plain Language Summary: Inmates are a vulnerable proportion of persons with epilepsy. In this group there are significant differences compared to the general population, especially with greater psychiatric comorbidity and worse control of epileptic seizures due to difficulties in accessing medical care, antiseizure medication and diagnostic tests. We found that the most characteristic population is made up of men in the fourth decade of life with a high frequency of seizures, most of whom were receiving multiple antiseizure medication This study is the first of its kind in Latin America and it is an initial approach to epilepsy in inmates.
- 15 June 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (4) , 1437-1444
Open AccessEpilepsy in inmate patients seen in a high complexity reference hospital in Colombia: A cross‐sectional study
Objective: To describe the sociodemographic and clinical characteristics of imprisoned patients with epilepsy seen at Samaritana University Hospital (HUS) in Bogotá D.C., between January 2017 and November 2020.Methods: Cross‐sectional cohort study of inmate patients over 18 years of age seen at HUS between January 2017 and November 2020, with a discharge diagnosis of epilepsy. A descriptive univariate analysis of patient sociodemographic and clinical characteristics was carried out.Results: Overall, 92 patients were included, 95.7% were males with a median age of 32 years (IQR: 26–44); 65% were assessed in the outpatient clinic; median hospital length of stay was 2 days (IQR: 0) and 7.6% required admission to the intensive care unit; 75% had focal onset epilepsy, 63.04% with undetermined etiology 31.52% with structural causes. Polytherapy was found in 53.3%, valproic acid being the most frequently used antiseizure medication in 59.78%; lack of adherence was reported in 15.22% and inadequate seizure control in 81.52%; status epilepticus occurred in 5.34%. A total of 31 EEG recordings and 53 brain images were performed, of which, 29% and 39.62%, respectively, were abnormal. Non‐epileptic paroxysmal events were diagnosed in 5.34%, while organic or psychiatric comorbidities were found in 25%, and the use of psychoactive substances was documented in 17.39%. Upon discharge, 93.47% had no disability, and only 45.65% returned for outpatient follow‐up.Significance: The clinical profile was of men in the fourth decade of life with focal onset epilepsy characterized by high seizure frequency, most of whom were receiving antiseizure medication, with a high proportion of polytherapy. The results are a point of departure for prospective studies designed to identify points to intervene and improve healthcare for inmates with epilepsy.Plain Language Summary: Inmates are a vulnerable proportion of persons with epilepsy. In this group there are significant differences compared to the general population, especially with greater psychiatric comorbidity and worse control of epileptic seizures due to difficulties in accessing medical care, antiseizure medication and diagnostic tests. We found that the most characteristic population is made up of men in the fourth decade of life with a high frequency of seizures, most of whom were receiving multiple antiseizure medication This study is the first of its kind in Latin America and it is an initial approach to epilepsy in inmates.
- Open Access
- 1 March 2022
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 7, 100131
Hypophosphatemic Rickets in Colombia: A Prevalence-Estimation Model in Rare Diseases. 2018
- 1 March 2022
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 7, 100131
Open AccessHypophosphatemic Rickets in Colombia: A Prevalence-Estimation Model in Rare Diseases. 2018